Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

Third Annual Healthcare Leadership Forum Expands to Include Multidisciplinary Evidence-Based Practice Across Healthcare

PHILADELPHIA, September 9, 2014--"Leveraging Evidence Across the Care Continuum" co-chaired by David Bates, MD, MSc, and Patricia Flatley Brennan, RN, PhD. The third annual Healthcare Leadership Forum, hosted by Clinical Innovation + Technology magazine and sponsored by Elsevier Clinical Solutions has expanded its mission this year to include multidisciplinary evidence-based practice and cooperative care. This meeting brings together physicians, nurses, IT and healthcare executives and leaders to share best practices for driving knowledge to the point of care, on Sept. 29-30 at the Waldorf Astoria Chicago.

First-of-Kind Health and Human Services Survey Drives Home Sustainability Concerns

OVERLAND PARK, Kan.--Integration with primary care, the emergence of health homes, Meaningful Use, and recovery-based care are among key topics in the ongoing transformation of behavioral health care. However, in the first annual Health and Human Services Influencing Factors Survey, providers demonstrated that while they are embracing rapid change, they are also concerned with long-term sustainability.

Thumbnail

Following up on JASON report

The Office of the National Coordinator for Health IT continues its focus on interoperability. One priority is the agency’s response to the JASON advisory group’s report on developing a data infrastructure for the nation’s healthcare system.

Telemedicine association shares which states make the grade

The American Telemedicine Association has released two state policy reports that serve as report cards to how states are faring at telemedicine coverage and reimbursement, as well as physician practice standards and licensure.

Telemedicine in Clinical Trials Highlighted at Upcoming Conferences

NEW YORK, Sept. 9, 2014-- Two of the most significant challenges in managing a successful clinical trial are recruiting the right test subjects and retaining them for the length of a trial. Time requirements, distance from the study site, number of site visits expected, and transportation concerns make it difficult to recruit patients for trials and contribute to high dropout rates, causing long delays and increasing the risk of trial failure.

Frost & Sullivan Commends eClinicalWorks CCMR®, a Comprehensive Analytical Platform for Population Health Management

MOUNTAIN VIEW, Calif., Sept. 8, 2014-- Based on its recent analysis of the population health management industry, Frost & Sullivan recognizes eClinicalWorks with the 2014 North America Frost & Sullivan Award for Enabling Technology Leadership. eClinicalWorks has reinforced its prominence in the ambulatory healthcare IT solutions market by developing the Care Coordination Medical Record® (CCMR®), a Web-based, dynamic and highly cross-functional platform for population health management and coordinated care.

Thumbnail

Recognizing Innovation

Despite all the questions and concerns surrounding the usability and interoperability of health IT, innovative, forward-thinking care delivery organizations are taking on the challenge of getting more out of their electronic tools.

Thumbnail

Saving Time & Money with Asynchronous Virtual Visits

With all of the regulatory initiatives facing physicians, Ronald Dixon, MD, set out to find a way to increase clinicians’ efficiency without sacrificing quality of care.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.